Antares Pharma, Inc. (ATRS)

Revenue

$41.56M

Quarterly · Period ending: · USD

ATRS logo

ATRS Revenue

Latest reported$41.56M
ATRS Quarterly Revenue ($400.00K → $41.56M)
High-resolution chart · PNG

ATRS revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Revenue — Quarterly (USD)
Period endingRevenue (USD)
1,000,000
1,291,804
900,000
800,000
400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.